Literature DB >> 7512153

Circulating anti-Tax cytotoxic T lymphocytes from human T-cell leukemia virus type I-infected people, with and without tropical spastic paraparesis, recognize multiple epitopes simultaneously.

C E Parker1, S Nightingale, G P Taylor, J Weber, C R Bangham.   

Abstract

CD8+ T cells were freshly isolated from a human T-cell leukemia virus type I (HTLV-I)-infected patient with tropical spastic paraparesis. These cells, which were specific for HTLV-I Tax, simultaneously recognized a minimum of five, and possibly as many as seven, distinct peptide epitopes within the protein. A further Tax epitope was recognized after a short period of culture without exogenous peptide stimulation. All but one of these epitopes were clustered in the N-terminal third of Tax, and one of the epitopes was clearly immunodominant on two separate occasions of testing. Recognition of the immunodominant epitope was restricted by human leukocyte antigen (HLA) B15, and recognition of all the others was by HLA A2. Similar patterns of cytotoxic T lymphocyte recognition of the HLA A2-restricted Tax peptides in two healthy HTLV-I-seropositive individuals, each of whom carried the HLA A2 allele, were observed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7512153      PMCID: PMC236774     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Rapid development of myelopathy after HTLV-I infection acquired by transfusion during cardiac transplantation.

Authors:  O Gout; M Baulac; A Gessain; F Semah; F Saal; J Périès; C Cabrol; C Foucault-Fretz; D Laplane; F Sigaux
Journal:  N Engl J Med       Date:  1990-02-08       Impact factor: 91.245

2.  Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I.

Authors:  E L Murphy; B Hanchard; J P Figueroa; W N Gibbs; W S Lofters; M Campbell; J J Goedert; W A Blattner
Journal:  Int J Cancer       Date:  1989-02-15       Impact factor: 7.396

3.  Detection of mRNA for the tax1/rex1 gene of human T-cell leukemia virus type I in fresh peripheral blood mononuclear cells of adult T-cell leukemia patients and viral carriers by using the polymerase chain reaction.

Authors:  T Kinoshita; M Shimoyama; K Tobinai; M Ito; S Ito; S Ikeda; K Tajima; K Shimotohno; T Sugimura
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

4.  T-lymphocyte alveolitis, tropical spastic paresis, and Sjögren syndrome.

Authors:  J C Vernant; G Buisson; J Magdeleine; J De Thore; A Jouannelle; C Neisson-Vernant; N Monplaisir
Journal:  Lancet       Date:  1988-01-23       Impact factor: 79.321

5.  The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I.

Authors:  J E Kaplan; M Osame; H Kubota; A Igata; H Nishitani; Y Maeda; R F Khabbaz; R S Janssen
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

6.  Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease.

Authors:  S Jacobson; H Shida; D E McFarlin; A S Fauci; S Koenig
Journal:  Nature       Date:  1990-11-15       Impact factor: 49.962

7.  Abrogation of simian virus 40 DNA-mediated transformation of primary C57BL/6 mouse embryo fibroblasts by exposure to a simian virus 40-specific cytotoxic T-lymphocyte clone.

Authors:  H E Karjalainen; M J Tevethia; S S Tevethia
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103

8.  In vivo cellular tropism of human T-cell leukemia virus type 1.

Authors:  J H Richardson; A J Edwards; J K Cruickshank; P Rudge; A G Dalgleish
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

9.  Infective dermatitis of Jamaican children: a marker for HTLV-I infection.

Authors:  L LaGrenade; B Hanchard; V Fletcher; B Cranston; W Blattner
Journal:  Lancet       Date:  1990-12-01       Impact factor: 79.321

10.  Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen.

Authors:  A Townsend; J Bastin; K Gould; G Brownlee; M Andrew; B Coupar; D Boyle; S Chan; G Smith
Journal:  J Exp Med       Date:  1988-10-01       Impact factor: 14.307

View more
  36 in total

1.  Human T-cell leukemia virus type 1 Tax protein binds to assembled nuclear proteasomes and enhances their proteolytic activity.

Authors:  J Hemelaar; F Bex; B Booth; V Cerundolo; A McMichael; S Daenke
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

Review 2.  Neuroimmunity of HTLV-I Infection.

Authors:  Eiji Matsuura; Yoshihisa Yamano; Steven Jacobson
Journal:  J Neuroimmune Pharmacol       Date:  2010-05-02       Impact factor: 4.147

3.  Presentation of human T cell leukemia virus type 1 (HTLV-1) Tax protein by dendritic cells: the underlying mechanism of HTLV-1-associated neuroinflammatory disease.

Authors:  Sharrón L Manuel; Todd D Schell; Edward Acheampong; Saifur Rahman; Zafar K Khan; Pooja Jain
Journal:  J Leukoc Biol       Date:  2009-08-05       Impact factor: 4.962

Review 4.  Class I HLA-restricted cytotoxic T lymphocyte responses against malaria--elucidation on the basis of HLA peptide binding motifs.

Authors:  D L Doolan; B Wizel; S L Hoffman
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

5.  OX40 signaling renders adult T-cell leukemia cells resistant to Fas-induced apoptosis.

Authors:  Akane Kunitomi; Toshiyuki Hori; Michiyuki Maeda; Takashi Uchiyama
Journal:  Int J Hematol       Date:  2002-10       Impact factor: 2.490

6.  Lymphoid organs as a major reservoir for human T-cell leukemia virus type 1 in experimentally infected squirrel monkeys (Saimiri sciureus): provirus expression, persistence, and humoral and cellular immune responses.

Authors:  M Kazanji; A Ureta-Vidal; S Ozden; F Tangy; B de Thoisy; L Fiette; A Talarmin; A Gessain; G de Thé
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

Review 7.  Human T-lymphotropic virus type 1 (HTLV-1): persistence and immune control.

Authors:  Charles R M Bangham
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

8.  Development of a cytotoxic T-cell assay in rabbits to evaluate early immune response to human T-lymphotropic virus type 1 infection.

Authors:  Rashade A H Haynes; Andrew J Phipps; Brenda Yamamoto; Patrick Green; Michael D Lairmore
Journal:  Viral Immunol       Date:  2009-12       Impact factor: 2.257

9.  Evolution in a chronic RNA virus infection: selection on HTLV-I tax protein differs between healthy carriers and patients with tropical spastic paraparesis.

Authors:  S Niewiesk; C R Bangham
Journal:  J Mol Evol       Date:  1996-04       Impact factor: 2.395

10.  HLA class I binding of HBZ determines outcome in HTLV-1 infection.

Authors:  Aidan Macnamara; Aileen Rowan; Silva Hilburn; Ulrich Kadolsky; Hiroshi Fujiwara; Koichiro Suemori; Masaki Yasukawa; Graham Taylor; Charles R M Bangham; Becca Asquith
Journal:  PLoS Pathog       Date:  2010-09-23       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.